 Response Lambert-Eaton myasthenic syndrome treatment small-cell lung carcinoma outcome patients Lambert-Eaton myasthenic syndrome LEMS small-cell carcinoma SCC Thirteen patients specific tumor therapy chemotherapy radiation therapy resection pharmacologic immunologic treatment LEMS Seven patients months tumor therapy substantial neurologic improvement patient complete remission years improvement transient EMG index disease severity compound muscle action potential amplitude abductor digiti minimi final follow-up pretreatment amplitude mV good prognostic sign combined treatment approach SCC-LEMS results neurologic improvement